Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: A voxel-based structural MRI study

Frontiers in Psychiatry

Volumn 4, Issue MAR, 2013, Pages

  Nakamura, Kazue ^a   Takahashi, Tsutomu ^a,b   Nemoto, Kiyotaka ^c   Furuichi, Atsushi ^a   Nishiyama, Shimako ^a   Nakamura, Yumiko ^a   Ikeda, Eiji ^a   Kido, Mikio ^a   Noguchi, Kyo ^a   Seto, Hikaru ^a   Suzuki, Michio ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cingulate gyrus; High risk; MRI; Psychosis; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SULPIRIDE; TANDOSPIRONE;

ADOLESCENT; ADULT; ANTERIOR CINGULATE; ARTICLE; AT RISK MENTAL STATE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIGH RISK PATIENT; HUMAN; LEFT ANTERIOR CINGULATE GYRUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SCHIZOPHRENIA; VOXEL BASED MORPHOMETRY;

EID: 84877688796     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00016     Document Type: Article

References (49)

1. Andreasen, N. C. (1983). The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
2. Andreasen, N. C. (1984). The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa.
3. Andreasen, N. C., Flaum, M., and Arndt,S. (1992). The comprehensive assessment of symptoms and history (CASH): an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49, 615-623.
4. Andreasen, N. C., Nopoulos, P., Magnotta, V., Pierson, R., Ziebell, S., and Ho, B. C. (2011). Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol. Psychiatry 70, 672-679.
5. Ashburner, J. (2007). A fast diffeomorphic image registration algorithm. Neuroimage 38, 95-113.
6. Ashburner, J., and Friston, K. J. (2005). Unified segmentation. Neuroimage 26, 839-851.
7. Ashburner, J., and Friston, K. J. (2009). Computing average shaped tissue probability templates. Neuroimage 45, 333-341.
8. Birchwood, M., Todd, P., and Jackson, C. (1998). Early intervention in psychosis: the critical-period hypothesis. Br. J. Psychiatry Suppl. 172, 53-59.
9. Borgwardt, S. J., Riecher-Rössler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., et al. (2007). Regional gray matter volume abnormalities in the at risk mental state. Biol. Psychiatry 61, 1148-1156.
10. Ellison-Wright, I., Glahn, D. C., Laird, A. R., Thelen, S. M., and Bullmore, E. (2008). The anatomy of first episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am. J. Psychiatry 165, 1015-1023.
11. Fornito, A., Yung, A. R., Wood, S. J., Phillips, L. J., Nelson, B., Cotton, S., et al. (2008). Anatomic abnormalities of the anterior cingulate cortex before psychosis onset:an MRI study of ultra-high-risk individuals. Biol. Psychiatry 64, 758-765.
12. Fusar-Poli, P., Bonoldi, I., Yung, A. R., Borgwardt, S., Kempton, M. J., Valmaggia, L., et al. (2012). Predicting psychosis, meta-analysis of transition outcomes in individuals at high clinical risk. Arch. Gen. Psychiatry 69, 220-229.
13. Fusar-Poli, P., Borgwardt, S., Crescini, A.,Deste,G.,Kempton,M. J.,Lawrie, S., et al. (2011). Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 35, 1175-1185.
14. Gaser, C. (2009). Voxel-Based Morphometry Toolbox, Version 8 (vbm8). Available at: http://dbm.neuro.unijena.de
15. Girgis, R. R., Diwadkar, V. A., Nutche, J. J., Sweeney, J. A., Keshavan, M. S., and Hardan, A. Y. (2006). Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr. Res. 82, 89-94.
16. Hayasaka, S., Phan, K. L., Liberzon, I., Worsley, K. J., and Nichols, T. E. (2004). Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22, 676-687.
17. Jones, D. K., Symms, M. R., Cercignani, M., and Howard, R. J. (2005). The effect of filter size on VBM analyses of DT-MRI data. Neuroimage 26, 546-554.
18. Klein, A., Anderson, J., Ardekani, B. A., Ashburner, J., Avants, B., Chiang, M. C., et al. (2009). Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46, 786-802.
19. Koo, M. S., Levitt, J. L., Salisbury, D. F., Nakamura, M., Shenton, M. E., and McCarley, R. W. (2008). A crosssectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch. Gen. Psychiatry 65, 746-760.
20. Lappin, J. M., Morgen, K., Morgen, C., Hutchison, G., Chitnis, X., Sucking, J., et al. (2006). Gray matter abnormalities associated with duration of untreated psychosis. Schizophr. Res. 83, 145-153.
21. Leung, M., Cheung, C., Yu, K., Yip, B., Sham, P., Li, Q., et al. (2011). Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr. Bull. 37, 199-211.
22. Lieberman, J. A., Tollefson, G. D., Charles, C., Zipursky, R., Sharma, T., Kahn, R. S., et al. (2005). Antipsychotic drug effects on brain morphology in first-episode schizophrenia. Arch. Gen. Psychiatry 62, 361-370.
23. Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P., and Croudace, T. (2005).Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 62, 975-983.
24. McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T., Woods, S. W., et al. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am. J. Psychiatry 163, 790-799.
25. McGorry, P. D., Hickie, I. B., Yung, A. R., Pantelis, C., and Jackson, H. J. (2006). Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 40, 616-622.
26. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59, 921-928.
27. Mechelli, A., Riecher-Rössler, A., Meisenzahl, E. M., Tognin, S., Wood, S. J., Borgwardt, S. J., et al. (2011). Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch. Gen. Psychiatry 68, 489-495.
28. Meisenzahl, E. M., Koutsouleris, N., Gaser, C., Bottelender, R., Schmitt, G. J. E., McGuire, P., et al. (2008). Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr. Res. 102, 150-162.
29. Mizuno, M., Suzuki, M., Matsumoto, K., Murakami, M., Takeshi, K., Miyakoshi, T., et al. (2009). Clinical practice and research activities for early psychiatric intervention at Japanese leading centres. Early Interv. Psychiatry 3, 5-9.
30. Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361, 281-288.
31. Perkins, D. O., Gu, H., Boteva, K., and Lieberman, J. A. (2005). Relationship between duration of untreated psychosis and outcome in firstepisode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 162, 1785-1804.
32. Salgado-Pineda, P., Baeza, I., Pérez-Gómez, M., Vendrell, P., Junqué, C., Bargalló, N., et al. (2003). Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 19, 365-375.
33. Salmond, C. H., Asburner, J., Vargha-Khadem, F., Connelly, A., Gadian, D. G., and Fristion, K. J. (2002). Distributional assumptions in voxelbased morphometry. Neuroimage 17, 1027-1030.
34. Schultz, C. C., Koch, K., Wagner, G., Roebel, M., Schachtzabel, C., Gaser, C., et al. (2010). Reduced cortical thickness in first episode schizophrenia. Schizophr. Res. 116, 204-209.
35. Shepherd, A. M., Laurens, K. R., Matheson, S. L., Carr, S. M., and Green, M. J. (2012). Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci. Biobehav. Rev. 36, 1342-1356.
36. Smieskova, R., Fusar-Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R. D., Drewe, J., et al. (2010). Neuroimaging predictors of transition to psychosis- a systematic review and metaanalysis. Neurosci. Biobehav. Rev. 34, 1207-1222.
37. Steen, R. G., Mull, C., McClure, R., Hamer, R. M., and Lieberman, J. A. (2006). Brain volume in first episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510-518.
38. Takahashi, T., Suzuki, M., Tanino, R., Zhou, S.-Y., Hagino, H., Niu, L., et al. (2007). Volume reduction of the left planum temporal gray matter associated with long duration of untreated psychosis in schizophrenia: preliminary report. Psychiatry Res. 154, 209-219.
39. Takahashi, T., Suzuki, M., Zhou, S.-Y., Tanino, R., Nakamura, K., Kawasaki, Y., et al. (2010). A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophr. Res. 119, 65-74.
40. Takahashi, T., Zhou, S.-Y., Nakamura, K., Tanino, R., Furuichi, A., Kido, M., et al. (2011). A follow-up MRI study of the fusiform gyrus and middle and inferior temporal gyri in schizophrenia spectrum. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1957-1964.
41. Talairach, J., and Tournoux, P. (1988). Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers.
42. Toru, M. (2001). Psychotropic Manual, 2nd Edn. Tokyo: Igaku-Shoin. (in Japanese).
43. Vita,A.,De Peri,L.,Silenzi,C.,and Dicci, M. (2006). Brain morphology in first-episode schizophrenia: a metaanalysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 82, 75-88.
44. Weiser,M.(2011). Earlyinterventionfor schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase. Am. J. Psychiatry 168, 761-763.
45. Woods, S. W., Tully, E. M., Walsh, B. C., Hawkins, K. A., Callahan, J. L., Cohen, S. J., et al. (2007). Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br. J. Psychiatry 191, 96-101.
46. World Health Organization. (1993). The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization.
47. Worsley, K. J., Andermann, M., Koulis, T., MacDonald, D., and Evans, A. C. (1999). Detecting changes in nonisotropic images. Hum. Brain Mapp. 8, 98-101.
48. Yung, A. R., Phillips, L. J., and McGorry, P. D. (2004). Treating Schizophrenia in the Prodromal Phase. London: Taylor & Francis.
49. Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., et al. (2003). Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr. Res. 60, 21-32.